109 related articles for article (PubMed ID: 8053061)
1. A human minor histocompatibility antigen which appears to segregate with the major histocompatibility complex.
Vinci G; Masset M; Semana G; Vernant JP
Transplantation; 1994 Aug; 58(3):361-7. PubMed ID: 8053061
[TBL] [Abstract][Full Text] [Related]
2. Multiple minor histocompatibility antigen-specific cytotoxic T lymphocyte clones can be generated during graft rejection after HLA-identical bone marrow transplantation.
Marijt WA; Kernan NA; Diaz-Barrientos T; Veenhof WF; O'Reilly RJ; Willemze R; Falkenburg JH
Bone Marrow Transplant; 1995 Jul; 16(1):125-32. PubMed ID: 7581111
[TBL] [Abstract][Full Text] [Related]
3. A novel minor histocompatibility antigen recognized by HLA-A31 restricted cytotoxic T lymphocytes generated from HLA-identical bone marrow donor lymphocytes.
Yazaki M; Takahashi T; Andho M; Akatsuka Y; Ito T; Miyake Y; Ito Y; Nakamura S; Wada Y
Bone Marrow Transplant; 1999 Jul; 24(2):129-37. PubMed ID: 10455340
[TBL] [Abstract][Full Text] [Related]
4. Mismatches for two major and one minor histocompatibility antigen correlate with a patient's rejection of a bone marrow graft from a serologically HLA-identical sibling.
Lienert-Weidenbach K; Valiante NM; Brown C; White C; Johnston-Dow L; McGinnis M; Krausa P; Lakes DM; Wolf JL; Blume KG; Parham P
Biol Blood Marrow Transplant; 1997 Nov; 3(5):255-60. PubMed ID: 9450920
[TBL] [Abstract][Full Text] [Related]
5. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
[TBL] [Abstract][Full Text] [Related]
6. A human autoreactive T cell line specific for minor histocompatibility antigen(s) isolated from a bone marrow-grafted patient.
Tilkin AF; Bagot M; Kayibanda M; Vernant JP; Levy JP
J Immunol; 1986 Dec; 137(12):3772-6. PubMed ID: 3537123
[TBL] [Abstract][Full Text] [Related]
7. Minor histocompatibility antigen-specific, leukemia-reactive cytotoxic T cell clones can be generated in vitro without in vivo priming using chronic myeloid leukemia cells as stimulators in the presence of alpha-interferon.
Faber LM; van Luxemburg-Heijs SA; Rijnbeek M; Willemze R; Falkenburg JH
Biol Blood Marrow Transplant; 1996 Feb; 2(1):31-6. PubMed ID: 9078352
[TBL] [Abstract][Full Text] [Related]
8. The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT).
Bishara A; Amar A; Brautbar C; Condiotti R; Lazarovitz V; Nagler A
Exp Hematol; 1995 Dec; 23(14):1667-75. PubMed ID: 8542963
[TBL] [Abstract][Full Text] [Related]
9. Localization to chromosome 22 of a gene encoding a human minor histocompatibility antigen.
Gubarev MI; Jenkin JC; Leppert MF; Buchanan GS; Otterud BE; Guilbert DA; Beatty PG
J Immunol; 1996 Dec; 157(12):5448-54. PubMed ID: 8955193
[TBL] [Abstract][Full Text] [Related]
10. 'Resistance' to unrelated, DLA-nonidentical canine marrow grafts is unrestricted by the major histocompatibility complex.
Raff RF; Sandmaier BM; Graham T; Loughran TP; Pettinger M; Storb R
Exp Hematol; 1994 Aug; 22(9):893-7. PubMed ID: 8062888
[TBL] [Abstract][Full Text] [Related]
11. Recognition of a B cell leukemia-associated minor histocompatibility antigen by CTL.
Dolstra H; Fredrix H; Preijers F; Goulmy E; Figdor CG; de Witte TM; van de Wiel-van Kemenade E
J Immunol; 1997 Jan; 158(2):560-5. PubMed ID: 8992968
[TBL] [Abstract][Full Text] [Related]
12. Clinical consequences of sensitisation to minor histocompatibility antigens before allogeneic bone marrow transplantation.
Rufer N; Starobinski M; Chapuis B; Gratwohl A; Jeannet M; Helg C; Roosnek E
Bone Marrow Transplant; 1998 Nov; 22(9):895-8. PubMed ID: 9827818
[TBL] [Abstract][Full Text] [Related]
13. Family segregation analysis of inheritance of human minor histocompatibility antigen.
Nishimura M; Mitsunaga S; Uchikawa C; Takahashi K; Tokunaga K; Tadokoro K; Juji T
Cell Immunol; 1995 Jul; 163(2):319-22. PubMed ID: 7606803
[TBL] [Abstract][Full Text] [Related]
14. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease.
Mutis T; Gillespie G; Schrama E; Falkenburg JH; Moss P; Goulmy E
Nat Med; 1999 Jul; 5(7):839-42. PubMed ID: 10395333
[TBL] [Abstract][Full Text] [Related]
15. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R
Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
[TBL] [Abstract][Full Text] [Related]
16. Bi-directional allelic recognition of the human minor histocompatibility antigen HB-1 by cytotoxic T lymphocytes.
Dolstra H; de Rijke B; Fredrix H; Balas A; Maas F; Scherpen F; Aviles MJ; Vicario JL; Beekman NJ; Ossendorp F; de Witte TM; van de Wiel-van Kemenade E
Eur J Immunol; 2002 Oct; 32(10):2748-58. PubMed ID: 12355426
[TBL] [Abstract][Full Text] [Related]
17. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
Russell CA
Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
[TBL] [Abstract][Full Text] [Related]
18. Allograft infiltrating cytotoxic T lymphocytes recognize kidney-specific human minor histocompatibility antigens.
Poindexter N; Shenoy S; Howard T; Flye MW; Mohanakumar T
Clin Transplant; 1997 Jun; 11(3):174-7. PubMed ID: 9193838
[TBL] [Abstract][Full Text] [Related]
19. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
Keever-Taylor CA; Bredeson C; Loberiza FR; Casper JT; Lawton C; Rizzo D; Burns WH; Margolis DA; Vesole DH; Horowitz M; Zhang MJ; Juckett M; Drobyski WR
Biol Blood Marrow Transplant; 2001; 7(11):620-30. PubMed ID: 11760150
[TBL] [Abstract][Full Text] [Related]
20. A class II-restricted cytotoxic T-cell clone recognizes a human minor histocompatibility antigen with a restricted tissue distribution.
Holloway PA; Kaldenhoven N; Kok-Schoemaker HM; Dijk Mv; Otten HG; Tilanus M; Postma S; Mutis T; Lokhorst HM; Bloem AC
Br J Haematol; 2005 Jan; 128(1):73-81. PubMed ID: 15606552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
